Prestige Consumer Healthcare (PBH) Enterprise Value (2010 - 2026)
Prestige Consumer Healthcare (PBH) posted quarterly Enterprise Value of -$62.4 million for Q4 2025, down 22.6% year-over-year from -$80.6 million in Q4 2024, and up 47.63% quarter-over-quarter from -$119.1 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Enterprise Value (2010 - 2026) Analysis & Trends
Prestige Consumer Healthcare's Enterprise Value history runs 16 years deep, the most recent figure standing at -$62.4 million for Q4 2025.
- In Q4 2025, Enterprise Value fell 22.6% year-over-year to -$62.4 million; the TTM figure through Dec 2025 stood at -$62.4 million (down 22.6% YoY), while the FY2025 annual figure was -$97.9 million, down 110.64% from the prior year.
- Enterprise Value for Q4 2025 stood at -$62.4 million, up from -$119.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$21.0 million in Q4 2021, with the low at -$163.6 million in Q2 2021.
- The 5-year median for Enterprise Value is -$53.1 million (2023), against an average of -$64.5 million.
- Peak annual rise in Enterprise Value reached 78.08% in 2022, while the deepest fall reached 310.88% in 2022.
- Prestige Consumer Healthcare's Enterprise Value stood at -$21.0 million in 2021, then tumbled by 310.88% to -$86.4 million in 2022, then advanced by 26.34% to -$63.6 million in 2023, then increased by 20.03% to -$50.9 million in 2024, then declined by 22.6% to -$62.4 million in 2025.
- Business Quant data shows PBH's Enterprise Value at -$62.4 million in Q4 2025, -$119.1 million in Q3 2025, and -$139.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | -164.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.37 Bn | - | -63.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.87 Mn |
| Dec 31, 2025 | -62.37 Mn |
| Sep 30, 2025 | -119.11 Mn |
| Jun 30, 2025 | -139.50 Mn |
| Mar 31, 2025 | -97.88 Mn |
| Dec 31, 2024 | -50.87 Mn |
| Sep 30, 2024 | -51.54 Mn |
| Jun 30, 2024 | -34.26 Mn |
| Mar 31, 2024 | -46.47 Mn |
| Dec 31, 2023 | -63.62 Mn |
| Sep 30, 2023 | -60.07 Mn |
| Jun 30, 2023 | -54.58 Mn |
| Mar 31, 2023 | -58.49 Mn |
| Dec 31, 2022 | -86.36 Mn |
| Sep 30, 2022 | -42.44 Mn |
| Jun 30, 2022 | -35.87 Mn |
| Mar 31, 2022 | -27.19 Mn |
| Dec 31, 2021 | -21.02 Mn |
| Sep 30, 2021 | -42.82 Mn |
| Jun 30, 2021 | -163.62 Mn |